Fayez Estephan, MD, joined as an Assistant Professor of Medicine in the Division of Hematology & Oncology at the George Washington School of Medicine and Health Sciences and GW Cancer Center.
Dr. Estephan was awarded his Medical Degree from Damascus University Faculty of Medicine in Damascus, Syria. He completed his residency in Internal Medicine from MedStar Health System in Baltimore, Maryland. After practicing as an attending in Hospital Medicine, Dr. Estephan completed a three-year fellowship training in Hematology & Oncology from George Washington University (GW).
Prior to his Internal Medicine Residency, Dr. Estephan worked as a post-doctoral research fellow at the Cleveland Clinic in a lab focused on malignant blood disorders. During his residency, he pursued post-doctoral oncology research training at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, where he focused on primary central nervous system lymphoma. As a fellow at GW, he developed an interest in solid tumors and joined a research project focused on prostate cancer therapeutic targets and biomarkers.
Dr. Estephan has published in peer-reviewed journals and is a member of the American Society of Clinical Oncology and the American Society of Hematology. His special interests include gastrointestinal and genitourinary malignancies.
Dr. Estephan is committed to his patients' care and dedicated to providing the best available individualized therapies to them.
Dr. Estephan is board certified in Internal Medicine, and board eligible for Medical Oncology and Hematology. He is licensed in the District of Columbia.
Coen J. Lap, MD, PhD, Rithika Rajendran, MD, Jose Manuel Martin, MD, Manisha Uppal, MD, Asha Escobar, MBBS, MPH, Angela M. Heiraty, PharmD, Fayez Estephan, MD, Winnie Hahn, MD, Ramesh Subrahmanyam, PhD, Victor E. Nava, MD, PhD, and Maneesh Jain, MD, MS, Response of Human Epidermal Growth Factor Receptor 2–Expressing Prostate Cancer to Trastuzumab Deruxtecan. Annals of Internal Medicine. November 5, 2024.
Fayez Estephan, Coen J. Lap, Jeff Banagan, Martha Antonio, Shanshan Liu, Guoqing Diao, Alexandra Zara Rozalen, Rithika Rajendran, Steven Krasnow, Ramesh Subrahmanyam, Victor E. Nava, Maneesh Jain, The prevalence and clinical significance of HER2 expression in prostate adenocarcinoma. Annals of Diagnostic Pathology · Oct 20, 2023
Fayez Estephan, Xiaobu Ye, Omar Dzaye, Nina Wagner-Johnston, Lode Swinnen, Douglas E. Gladstone, Rich Ambinder, David Olayinka Kamson, Sebastian Lambrecht, Stuart A. Grossman, Doris D. M. Lin & Matthias Holdhoff, White matter changes in primary central nervous system lymphoma patients treated with high-dose methotrexate with or without rituximab. Journal of Neuro-Oncology · Oct 16, 2019
James D. Phelan, Ryan M. Young, Daniel E. Webster, Sandrine Roulland, George W. Wright, Monica Kasbekar, Arthur L. Shaffer III, Michele Ceribelli, James Q. Wang, Roland Schmitz, Masao Nakagawa, Emmanuel Bachy, Da Wei Huang, Yanlong Ji, Lu Chen, Yandan Yang, Hong Zhao, Xin Yu, Weihong Xu, Maryknoll M. Palisoc, Racquel R. Valadez, Theresa Davies-Hill, Wyndham H. Wilson, Wing C. Chan, …Louis M. Staudt, A multiprotein supercomplex controlling oncogenic signaling in lymphoma. Nature Journal · Jun 20, 2018
Fayez Estephan,Heesun J. Rogers,Valeria Visconte,Ali Tabarroki,Jing Ai,Hien K. Duong,Matt Kalaycio &Ramon V. Tiu,
Spontaneous recovery of severe nilotinib-induced bone marrow aplasia and successful retreatment with dasatinib in a patient with Chronic Phase Chronic Myeloid Leukemia. Leukemia and Lymphoma Journal · Mar 15, 2015
Fayez Estephan, Current and novel therapeutic approaches in myelodysplastic syndromes. Journal of Community and Supportive Oncology · Jul 12, 2014